The company’s board of directors resolved on May 13, 2026 to issue employee stock options totaling 8,800,000 units. Each option unit entitles the holder to subscribe for one common share, and the total number of new shares to be issued upon exercise is 8,800,000 shares. The options may be issued in one or multiple tranches within two years from the effective date of the regulatory filing. The actual issuance date is authorized to be determined by the chairperson. Eligible optionees are full-time and part-time employees of the company and its domestic or overseas subsidiaries who are employed before the eligibility record date, which will be determined by the chairperson. The actual eligible employees and number of options granted will be determined based on the company’s operating results, the employee’s rank, job scope, performance evaluation, past and expected overall contribution, special contribution, development potential and other appropriate factors. Grants to directors or managerial officers must first be approved by the remuneration committee; grants to other employees must first be approved by the audit committee, and then submitted to the board for approval. The exercise price will be the closing price of the company’s common shares on the issuance date of the employee stock options. If the closing price is lower than par value, the par value of the common shares will be used as the exercise price. The options have a term of 10 years from the issuance date. Any unexercised options after expiry will be deemed waived. The options may not be transferred, pledged, gifted or otherwise disposed of, except where statutory heirs acquire the rights upon the death of an optionee. The options may be exercised in stages after three full years from the grant date: up to 30% after three years, up to 70% after four years, and up to 100% after five years. Within the scope permitted by law, the board may adjust or amend the vesting periods and vesting ratios for each issu